P497 injection site reactions and injection site pain for the adalimumab biosimilar ABP 501: Results from two double-blind, randomised, controlled studies

Authors
Category Primary study
JournalJ Crohns Colitis
Year 2018
This article has no abstract
Epistemonikos ID: 5b1acecc3da5f2213763547ba4c9b58304934ef8
First added on: Dec 20, 2021